Yahoo
NasdaqCM - Nasdaq Real Time Price USD

DataMEDS AI, Inc. (MEDS)

1.1800 -0.0400 (-3.28%)
At close: November 6 at 4:00:01 PM EST
1.1963 +0.0163 (+1.38%)
Pre-Market: 5:06:12 AM EST
Chart Range Bar
Loading chart for MEDS
  • Previous Close 1.2200
  • Open 1.2000
  • Bid 1.1900 x 500
  • Ask 2.0800 x 100
  • Day's Range 1.1350 - 1.2399
  • 52 Week Range 0.8230 - 35.5000
  • Volume 120,845
  • Avg. Volume 6,524,609
  • Market Cap (intraday) 6.115M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -46.6800
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provides clinical concierge services. DataMEDS AI, Inc., through its subsidiary develops and delivers a portfolio of products to guide physicians and patients with difficult clinical decisions throughout the cancer care continuum. In addition, the company develops and provides functional precision medicine oncology platform. The company was formerly known as Wellgistics Health, Inc. and changed its name to DataMEDS AI, Inc. in July 2026. DataMEDS AI, Inc. was incorporated in 2022 and is based in Tampa, Florida.

datamedsai.com

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/6/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

MEDS
94.10%
S&P 500 (^GSPC)
7.76%

1-Year Return

MEDS
96.58%
S&P 500 (^GSPC)
9.77%

3-Year Return

MEDS
99.46%
S&P 500 (^GSPC)
68.96%

5-Year Return

MEDS
99.46%
S&P 500 (^GSPC)
57.04%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -82.93%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    8.02M

  • Net Income Avi to Common (ttm)

    -88.28M

  • Diluted EPS (ttm)

    -46.6800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.46M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    2.37M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: